Company Description
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.
It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories.
The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Country | United States |
Founded | 1952 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 8,030 |
CEO | Dr. Andrew J. Last Ph.D. |
Contact Details
Address: 1000 Alfred Nobel Drive Hercules, California 94547 United States | |
Phone | (510) 724-7000 |
Website | bio-rad.com |
Stock Details
Ticker Symbol | BIO |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000012208 |
CUSIP Number | 090572207 |
ISIN Number | US0905722072 |
Employer ID | 94-1381833 |
SIC Code | 3826 |
Key Executives
Name | Position |
---|---|
Norman D. Schwartz | Chairman, Chief Executive Officer, President and Principal Financial Officer |
Dr. Andrew J. Last Ph.D. | Executive Vice President and Chief Operating Officer |
Dr. Simon May | Executive Vice President and President of the Life Science Group |
Tania DeVilliers | Senior Director, Corporate Controller and Interim Principal Accounting Officer |
Yong Chung | Vice President of Investor Relations |
Timothy S. Ernst | Executive Vice President, General Counsel and Secretary |
Matthew Werner | Senior Vice President and Chief Compliance and Privacy Officer |
Colleen Corey | Executive Vice President of Global Human Resources |
Michael Crowley | Executive Vice President of Global Commercial Operations |
Lee Boyd | Senior Vice President of Global Commercial Operations - Asia Pacific |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 10, 2024 | 8-K | Current Report |
Mar 27, 2024 | DEF 14A | Other definitive proxy statements |
Mar 27, 2024 | ARS | Filing |
Mar 20, 2024 | 8-K | Current Report |
Mar 11, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 28, 2024 | 144 | Filing |
Feb 27, 2024 | 144 | Filing |
Feb 27, 2024 | 144 | Filing |
Feb 21, 2024 | 8-K | Current Report |
Feb 16, 2024 | 10-K | Annual Report |